Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
Veronese A, Pepe F, Chiacchia J, Pagotto S, Lanuti P, Veschi S, Di Marco M, D'Argenio A, Innocenti I, Vannata B, Autore F, Marchisio M, Wernicke D, Verginelli F, Leone G, Rassenti LZ, Kipps TJ, Mariani-Costantini R, Laurenti L, Croce CM, Visone R. Veronese A, et al. Among authors: innocenti i. Leukemia. 2015 Jan;29(1):86-95. doi: 10.1038/leu.2014.139. Epub 2014 Apr 15. Leukemia. 2015. PMID: 24732594 Free PMC article.
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
Laurenti L, Tarnani M, De Padua L, Efremov DG, Zini G, Garzia M, Piccirillo N, Chiusolo P, Sorà F, Innocenti I, Sica S, Leone G. Laurenti L, et al. Among authors: innocenti i. Ann Hematol. 2008 Nov;87(11):891-8. doi: 10.1007/s00277-008-0527-3. Epub 2008 Jun 28. Ann Hematol. 2008. PMID: 18587576 Clinical Trial.
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
Laurenti L, Tarnani M, Innocenti I, Savino G, Battendieri R, Larocca LM, Chiusolo P, Sorà F, Sica S, Efremov D, Leone G. Laurenti L, et al. Among authors: innocenti i. J Clin Oncol. 2008 Nov 10;26(32):5299-301. doi: 10.1200/JCO.2008.18.6270. Epub 2008 Oct 14. J Clin Oncol. 2008. PMID: 18854557 No abstract available.
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
Laurenti L, De Padua L, Tarnani M, Piccirillo N, Falcucci P, D'Arena G, Innocenti I, Marietti S, Efremov DG, Chiusolo P, Zini G, Sora' F, Sica S, Leone G. Laurenti L, et al. Among authors: innocenti i. Ann Hematol. 2011 Jan;90(1):59-65. doi: 10.1007/s00277-010-1025-y. Epub 2010 Jul 13. Ann Hematol. 2011. PMID: 20625902
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience.
Laurenti L, Vannata B, Innocenti I, Autore F, Santini F, Piccirillo N, Za T, Bellesi S, Marietti S, Sica S, Efremov DG, Leone G. Laurenti L, et al. Among authors: innocenti i. Mediterr J Hematol Infect Dis. 2013 May 2;5(1):e2013031. doi: 10.4084/MJHID.2013.031. Print 2013. Mediterr J Hematol Infect Dis. 2013. PMID: 23667729 Free PMC article.
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.
De Padua L, Laurenti L, Falcucci P, D'arena G, Vannata B, Innocenti I, Autore F, Piccirillo N, Za T, Marietti S, Efremov DG, Sica S. De Padua L, et al. Among authors: innocenti i. Ann Hematol. 2014 Jul;93(7):1261-2. doi: 10.1007/s00277-013-1968-x. Epub 2013 Dec 5. Ann Hematol. 2014. PMID: 24306088 No abstract available.
123 results